The Evolving Role of CAR T Cell Therapy in Hematological Malignancies

EP. 1: CAR T-Cell Therapy in Pediatric ALL

December 23rd 2019

EP. 2: A Conversation on MRD in ALL

December 23rd 2019

EP. 3: Treating Common Toxicities From CAR T Therapy

December 23rd 2019

EP. 4: CAR T-Cell Therapy: Relapsed/Refractory ALL

December 23rd 2019

EP. 5: Adult ALL and Data from ZUMA-3

December 23rd 2019

EP. 6: High-Risk Lymphoma: The ZUMA-1 and SCHOLAR-1 Trials

December 23rd 2019

EP. 7: CAR-T Therapy Treatment Variables

December 23rd 2019

EP. 8: Real-World Data and CAR T Therapy

December 23rd 2019

EP. 9: CAR T Associated Cytokine Release Syndrome

December 23rd 2019

EP. 10: The TRANSCEND-NHL-001 Trial

December 23rd 2019

EP. 11: Expanded Use of CAR T Therapy in Hematologic Malignancies

December 23rd 2019

EP. 12: Next-Generation CAR T Therapy

December 23rd 2019

EP. 13: Anticipation of ZUMA-7 Results

December 23rd 2019

EP. 14: CAR T-Cell Therapy as an Outpatient Treatment Option

December 23rd 2019